Big Insurers Invest in Affordable Housing
UnitedHealth Group (UHG) will invest $25M into retail, housing and social services to promote healthier communities in New England. The insurer isn’t alone. CVS Health, Kaiser Permanente and Anthem have also recognized the benefits of affordable housing investments, pouring over $1B into affordable housing endeavors to date. The Deets UHG will invest $25M into the…
Read MoreOutside the Huddle #135
The Outside the Huddle section of the Healthcare Huddle newsletter contains quick-hit summaries of need-to-know news in the healthcare industry. Blake Madden’s H1 Healthcare Business Recap Blake Madden recapped the top 20 biggest healthcare business stories in 2022 so far. If you have any role in the healthcare business, you must read his article to…
Read MoreColorado Approved to Launch Public Option
Colorado is one of three states approved to implement its public option program after receiving approval from the Department of Health and Human Services (HHS). While the public option is excellent for consumers, how may hospitals and physicians feel about it? The Deets HHS approved Colorado’s public option plan (“Colorado Option”) under the Section 1332 State Innovation Waiver.…
Read MoreCalifornia to Produce its Own Insulin
California Governor Gavin Newsom announced his state would manufacture its own insulin to make the medication more affordable for Californians with insulin-dependent diabetes. Neither the federal government nor other states have made a direct effort to lower insulin prices. The Deets California will allocate $100M of its state budget to lower insulin costs: $50M allocated to build the…
Read MoreDifferent Care, Same City
Same, Same But Different Same age. Same sex. Same illness. Different treatment. This is unwarranted clinical variation; it is care that is not consistent with a patient’s preference or related to a patient’s underlying illness. The U.S. has a significant problem with unwarranted clinical variation, stemming from its inherent complexity. This isn’t a benign problem,…
Read MoreHealthcare Q2 ’22 Recap
BUSINESS The Netflix of Antibiotics The UK plans to use a subscription-based model for Pfizer and Shionogi to increase the supply of powerful antibiotics. The UK government will pay the two companies $13M/year over the decade for a guaranteed supply of two drugs, cefiderocol and ceftazidime-avibactam. This subscription model is known as a “pull incentive.” Such pull…
Read More